Jazz Pharmaceuticals Inc

Type: Company
Name: Jazz Pharmaceuticals Inc
First reported 21 hours ago - Updated 21 hours ago - 1 reports

Jazz Pharmaceuticals (JAZZ) Showing Support Near $152.42

After closing Tuesday at $159.35, Jazz Pharmaceuticals Inc. (JAZZ) presents an attractive opportunity to get a 6.79% return in just 87 days, which is an annualized return of 28.47% (for comparison purposes only). To enter this trade, sell one Jan. '15 ... [Published MarketIntelligenceCenter.com - 21 hours ago]
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

Jazz Pharma, Ulta Beauty: This Midcap Fund Likes Them

It's been a hostile stock market recently for mutual funds, especially midcap portfolios. Midcap stock mutual funds of all style types have suffered some of the biggest setbacks over the past 13 weeks of funds of any size and style. But a top mutual fund ... [Published Crawford Financial Planning - Oct 21 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 3 reports

Jazz Pharmaceuticals to Report 2014 Third Quarter Financial Results on November 4, 2014

DUBLIN, Oct. 21, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq:JAZZ) today announced that it will report its 2014 third quarter financial results on Tuesday, November 4, 2014, after the close of the financial markets. Company management will host ... [Published Nasdaq - Oct 21 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 1 reports

Jazz Pharmaceuticals (JAZZ) Trading Near $148.66 Support Level

Jazz Pharmaceuticals Inc. (JAZZ) is a good candidate for a covered call at the $150.00 level. The Dec. '14 call at that price should fetch a credit of about $11.10, which means the entire position has a net debit of about $141.29. This trade has 5.34% ... [Published MarketIntelligenceCenter.com - Oct 21 2014]
First reported Oct 14 2014 - Updated Oct 14 2014 - 1 reports

Jazz Pharmaceuticals Makes a Move: Up 3.7%

Up 3.7% to $148.01, Jazz Pharmaceuticals (NASDAQ:JAZZ), is one of today's notable movers. The S&P is trading higher by 0.9% to 1,892 and the Dow is trading 0.6% higher to 16,426. ... [Published Individual.com - Oct 14 2014]
First reported Oct 09 2014 - Updated Oct 10 2014 - 1 reports

Jazz Pharmaceuticals (JAZZ) Showing Bullish Technicals With Support At $149.91

After closing Wednesday at $159.74, Jazz Pharmaceuticals Inc. (JAZZ) presents an attractive opportunity to get a 5.27% return in just 72 days, which is an annualized return of 26.72% (for comparison purposes only). To enter this trade, sell one Dec. '14 ... [Published MarketIntelligenceCenter.com - Oct 09 2014]
First reported Oct 09 2014 - Updated Oct 09 2014 - 1 reports

Will Jazz Pharmaceuticals Dance Up The Chart?

Today we're going to look at Jazz Pharmaceuticals (JAZZ), which specializes in treatments for narcolepsy and rare diseases. In 2012, the company merged with Azure Pharma and moved its tax domicile to Ireland. Analysts say that shift has given Jazz more ... [Published Wall Street Business Network - Oct 09 2014]
First reported Oct 08 2014 - Updated Oct 08 2014 - 1 reports

Jazz Pharmaceuticals Partnering 2009 - 2014, New Report Launched

Market Research Reports, Inc. has announced the addition of "Jazz Pharmaceuticals Partnering 2009-2014" research report to their website http://www.MarketResearchReports.com ... [Published Individual.com - Oct 08 2014]
First reported Oct 08 2014 - Updated Oct 08 2014 - 1 reports

Jazz Pharmaceuticals Partnering 2009 - 2014, New Report Launched

Lewes, DE -- (SBWIRE) -- 10/08/2014 -- This report provides all the information you require to better understand Jazz Pharmaceuticals and its partnering interests and activities over the past five years. ... [Published CBS Detroit - Oct 08 2014]
First reported Oct 03 2014 - Updated Oct 03 2014 - 1 reports

Jazz Pharmaceuticals Find Support At 50-Day Average

Jazz Pharmaceuticals has been trading below its most recent buy point, but the stock got a boost Friday as shares bounced from the 50-day moving average. The stock rose sharply amid a broad market rally, erasing the losses suffered earlier in the week. ... [Published Wall Street Business Network - Oct 03 2014]
First reported Oct 03 2014 - Updated Oct 03 2014 - 2 reports

Jazz Pharmaceuticals Uses New Cash To Buy For Growth

Just a few years ago, one drug generated all but a small slice of revenue for Jazz Pharmaceuticals.And though the drug, Xyrem, targeted a small patient population of narcolepsy sufferers -- people prone to fall suddenly asleep in the middle of the day ... [Published Nasdaq - Oct 03 2014]
First reported Sep 26 2014 - Updated Sep 26 2014 - 1 reports

Potential Jazz Pharmaceuticals (JAZZ) Trade Targets 7.31% Return

Jazz Pharmaceuticals Inc. (JAZZ) traded between $159.36 and $165.99 before closing at $159.94 Thursday and presents some attractive trading opportunities today. MarketIntelligenceCenter.com’s algorithms have picked a Dec. '14 $155.00 covered call for ... [Published MarketIntelligenceCenter.com - Sep 26 2014]

Quotes

...University of Minnesota political scientist Larry Jacobs, referring to longtime Democratic incumbent Jim Oberstar's loss to Chip Cravaack in 2010. "Clearly Mills is benefiting from a fundamental change in the 8th District that is trending in the Republicans' direction."
"In one embodiment, the pump of the present invention is used for intrathecal administration, epidural administration, and administration to other sites in the body using an implantable pump. A preferred route of administration is intrathecal administration."

More Content

All (234) | News (66) | Reports (0) | Blogs (156) | Audio/Video (0) | Fact Sheets (0) | Press Releases (11)
sort by: Date | Relevance
Jazz Pharmaceuticals (JAZZ) Showing Support Nea... [Published MarketIntelligenceCenter.com - 21 hours ago]
Jazz Pharma, Ulta Beauty: This Midcap Fund Like... [Published Crawford Financial Planning - Oct 21 2014]
Jazz Pharmaceuticals to Report 2014 Third Quart... [Published Nasdaq - Oct 21 2014]
Jazz Pharmaceuticals to Report 2014 Third Quart... [Published Pettinga Financial Advisors - Oct 21 2014]
Jazz Pharmaceuticals to Report 2014 Third Quart... [Published PR Newswire: Health - Oct 21 2014]
Jazz Pharmaceuticals (JAZZ) Trading Near $148.6... [Published MarketIntelligenceCenter.com - Oct 21 2014]
Potential Jazz Pharmaceuticals (JAZZ) Trade Tar... [Published MarketIntelligenceCenter.com - Oct 20 2014]
Polling shows possible GOP pick-up of 2 'safe' ... [Published American Thinker - Oct 18 2014]
Jazz Pharmaceuticals (JAZZ) Trading Near $139.1... [Published MarketIntelligenceCenter.com - Oct 17 2014]
Franken’s Attacks on ‘Fat Cat’ Financiers Backfire [Published Washington Free Beacon - Oct 16 2014]
Jazz Pharmaceuticals (JAZZ) Showing Bearish Tec... [Published MarketIntelligenceCenter.com - Oct 16 2014]
"Methods of Administering Drugs in an Implantab... [Published Pharmacy Choice - Oct 16 2014]
Concert Pharmaceuticals Announces Positive CTP-... [Published Zacks.com - Oct 15 2014]
Jazz Pharmaceuticals (JAZZ) Trading Near $152.0... [Published MarketIntelligenceCenter.com - Oct 15 2014]
Court Report - October 2014 #2 [Published JD Supra - Oct 14 2014]
Jazz Pharmaceuticals Makes a Move: Up 3.7% [Published Individual.com - Oct 14 2014]
Top 10 Most Expensive Drugs of 2013 [Published P&T Community - Oct 14 2014]
Jazz Pharmaceuticals (JAZZ) Showing Resistance ... [Published MarketIntelligenceCenter.com - Oct 14 2014]
Jazz, TAL Teeter On Market Weakness [Published Crawford Financial Planning - Oct 14 2014]
Jazz Pharmaceuticals (JAZZ) Showing Support Nea... [Published MarketIntelligenceCenter.com - Oct 13 2014]
Franken crusades against tax deal [Published The Hill - Oct 12 2014]
Inversion Vitriol Vs. Drug Consolidation [Published Yahoo! Finance - Oct 10 2014]
Jazz Pharmaceuticals (JAZZ) Trading Near $150.7... [Published MarketIntelligenceCenter.com - Oct 10 2014]
Will Jazz Pharmaceuticals Dance Up The Chart? [Published Wall Street Business Network - Oct 09 2014]
Jazz Pharmaceuticals (JAZZ) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Oct 09 2014]
Jazz Pharmaceuticals Partnering 2009 - 2014, Ne... [Published CBS Detroit - Oct 08 2014]
Jazz Pharmaceuticals (JAZZ) Trading Near $151.4... [Published MarketIntelligenceCenter.com - Oct 08 2014]
Jazz Pharmaceuticals Partnering 2009 - 2014, Ne... [Published Individual.com - Oct 08 2014]
Jazz Pharmaceuticals (JAZZ) Showing Bullish Tec... [Published MarketIntelligenceCenter.com - Oct 07 2014]
Graft-versus-host disease market forecast to be... [Published Live-PR.com - Oct 07 2014]
1 2 3 4 5 6 7 8
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Jazz Pharmaceuticals (JAZZ) Showing Support Nea... [Published MarketIntelligenceCenter.com - 21 hours ago]
After closing Tuesday at $159.35, Jazz Pharmaceuticals Inc. (JAZZ) presents an attractive opportunity to get a 6.79% return in just 87 days, which is an annualized return of 28.47% (for comparison purposes only). To enter this trade, sell one Jan. '15 ...
Jazz Pharmaceuticals to Report 2014 Third Quart... [Published PR Newswire: Health - Oct 21 2014]
DUBLIN, Oct. 21, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2014 third quarter financial results on Tuesday, November 4, 2014, after the close of the financial markets.  Company management ...
Jazz Pharmaceuticals (JAZZ) Trading Near $148.6... [Published MarketIntelligenceCenter.com - Oct 21 2014]
Jazz Pharmaceuticals Inc. (JAZZ) is a good candidate for a covered call at the $150.00 level. The Dec. '14 call at that price should fetch a credit of about $11.10, which means the entire position has a net debit of about $141.29. This trade has 5.34% ...
Potential Jazz Pharmaceuticals (JAZZ) Trade Tar... [Published MarketIntelligenceCenter.com - Oct 20 2014]
The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center  are highlighting two trades on Jazz Pharmaceuticals Inc. (JAZZ) today after it closed at $152.36 on Friday. For more conservative investors, ...
Jazz Pharmaceuticals (JAZZ) Trading Near $139.1... [Published MarketIntelligenceCenter.com - Oct 17 2014]
Jazz Pharmaceuticals Inc. (JAZZ) is a good candidate for a covered call at the $150.00 level. The Dec. '14 call at that price should fetch a credit of about $10.50, which means the entire position has a net debit of about $139.76. This trade has 4.96% ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Jazz Pharmaceuticals Announces Pricing of $500 ... [Published Financial Services - Aug 08 2014]
The Zacks Analyst Blog Highlights: Medtronic, C... [Published Financial Services - Aug 01 2014]
Financial Results, Clinical Trial Initiations, ... [Published Financial Services - Jul 30 2014]
Biotech Companies Release Quarterly Financials ... [Published Financial Services - Jul 29 2014]
The Zacks Analyst Blog Highlights:Regado Biosci... [Published Financial Services - Jul 10 2014]
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.